Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma

Human Pathology

Volumn 41, Issue 9, 2010, Pages 1220-1230

  Gomez Brouchet, Anne ^a,b   Mourcin, Frédéric ^c   Gourraud, Pierre Antoine ^b   Bouvier, Corinne ^d   De Pinieux, Gonzague ^e   Le Guelec, Sophie ^a   Brousset, Pierre ^f   Delisle, Marie Bernadette ^a,b   Schiff, Claudine ^c  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^d TIMONE HOSPITAL   (France)

^e SERVICE DE DERMATOLOGIE   (France)

^f CHU PURPAN   (France)

Author keywords

Chondroblastic osteosarcoma; Chondrosarcoma; Diagnosis tool; Galectin 1; Immunohistochemistry; Osteosarcoma

Indexed keywords

GALECTIN 1; TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; CHONDROBLASTIC OSTEOSARCOMA; CHONDROSARCOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OSTEOBLAST; OSTEOSARCOMA; PREDICTIVE VALIDITY; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 77955927474     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.10.028     Document Type: Article

References (37)

1. Fletcher C.D.M., Unni K.K., and Mertens F. Pathology and genetics of soft tissue and bone 2002 IRC Press Lyon
2. Huvos A.G., Rosen G., and Marcove R.C. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement Arch Pathol Lab Med 101 1977 14 18
3. Rosen G., Caparros B., and Huvos A.G. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy Cancer 49 1982 1221 1230
4. Picci P. Osteosarcoma (osteogenic sarcoma) Orphanet J Rare Dis 2 2007 6
5. Koh J.S., Chung J.H., Lee S.Y., and Lee J.H. Chondrosarcoma of the proximal femur with myxoid degeneration mistaken for chondromyxoid fibroma in a young adult. A case report Acta Cytol 45 2001 254 258
6. Gupta K., Radhika S., and Vasishta R.K. Chondrosarcoma of calcanaeum in a 12-year-old male patient: a case report Diagn Cytopathol 31 2004 399 401
7. Mahesha V., Goyal R., Vaiphei K., Nada R., and Gupta A.K. Primary chondrosarcoma of ethmoid bone in a 6-year-old child Ann Diagn Pathol 10 2006 154 156
8. Komori T. Regulation of osteoblast differentiation by transcription factors J Cell Biochem 99 2006 1233 1239
9. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., and Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton Int J Biochem Cell Biol 40 2008 46 62
10. Salas S., de Pinieux G., and Gomez-Brouchet A. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma Virchows Arch 454 2009 81 87
11. Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins J Biol Chem 263 1988 9557 9560
12. Sharon N., and Lis H. Lectins as cell recognition molecules Science 246 1989 227 234
13. Bourne Y., Bolgiano B., and Liao D.I. Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides Nat Struct Biol 1 1994 863 870
14. Sanford G.L., and Harris-Hooker S. Stimulation of vascular cell proliferation by beta-galactoside specific lectins FASEB J 4 1990 2912 2918
15. Ellerhorst J., Nguyen T., Cooper D.N., Lotan D., and Lotan R. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype Int J Oncol 14 1999 217 224
16. Rorive S., Belot N., and Decaestecker C. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma Glia 33 2001 241 255 [Erratum in: Glia 2001 Aug;35(2):166]
17. Koh H.S., Lee C., and Lee K.S. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kappaB upon T-cell activation Biochem Biophys Res Commun 370 2008 149 153
18. Brandt B., Büchse T., and Abou-Eladab E.F. Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes Histochem Cell Biol 129 2008 599 609
19. Valenzuela H.F., Pace K.E., and Cabrera P.V. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1 Cancer Res 67 2007 6155 6162
20. Moiseeva E.P., Spring E.L., Baron J.H., and de Bono D.P. Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix J Vasc Res 36 1999 47 58
21. Van den Brûle F., Califice S., and Castronovo V. Expression of galectins in cancer: a critical review Glycoconj J 19 2004 537 542
22. Camby I., Belot N., and Lefranc F. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases J Neuropathol Exp Neurol 61 2002 585 596
23. Elola M.T., Wolfenstein-Todel C., Troncoso M.F., Vasta G.R., and Rabinovich G.A. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival Cell Mol Life Sci 64 2007 1679 1700
24. Kopitz J., von Reitzenstein C., and André S. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3 J Biol Chem 276 2001 35917 35923
25. Andersen H., Jensen O.N., Moiseeva E.P., and Eriksen E.F. A proteome study of secreted prostatic factors affecting osteoblastic activity: galectin-1 is involved in differentiation of human bone marrow stromal cells J Bone Miner Res 18 2003 195 203
26. Barondes S.H., Castronovo V., and Cooper D.N. Galectins: a family of animal beta-galactoside-binding lectins Cell 76 1994 597 598
27. Camby I., Le Mercier M., Lefranc F., and Kiss R. Galectin-1: a small protein with major functions Glycobiology 16 2006 137R 157R
28. Thijssen V.L., Postel R., and Brandwijk R.J. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy Proc Natl Acad Sci U S A 103 2006 15975 15980
29. Satelli A., Rao P.S., Gupta P.K., Lockman P.R., Srivenugopal K.S., and Rao U.S. Varied expression and localization of multiple galectins in different cancer cell lines Oncol Rep 19 2008 587 594
30. Cindolo L., Benvenuto G., and Salvatore P. Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas Int J Cancer 84 1999 39 43
31. Chiariotti L., Berlingieri M.T., and Battaglia C. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors Int J Cancer 64 1995 171 175
32. Xu X.C., el-Naggar A.K., and Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications Am J Pathol 147 1995 815 822
33. Jung E.J., Moon H.G., and Cho B.I. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer Int J Cancer 120 2007 2331 2338
34. Kononen J., Bubendorf L., and Kallioniemi A. Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
35. Rossi B., Espeli M., Schiff C., and Gauthier L. Clustering of pre-B cell integrins induces galectin-1 dependent pre-B cell receptor relocalization and activation J Immunol 177 2006 796 803
36. Ludbrook J. Statistical techniques for comparing measurers and methods of measurement: a critical review Clin Exp Pharmacol Physiol 29 2002 527 536
37. Malpica A., Matisic J.P., and Niekirk D.V. Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues Gynecol Oncol 99 3 Suppl 1 2005 S38 S52